Finance
Results: 20341-20352 of 40215

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union

ProLogium Sets Record-Breaking Standards in Battery Safety and Energy Density Ahead of Schedule with TÜV Rheinland Certification









